sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608

Contraceptive Devices Market Size & Forecast

Download Free Sample View Report Summary
Historic: 2022-2024 Base Year: 2025 Forecast: 2026–2033
US$ 28.22 Billion
Market Size 2025 · Base Year
US$ 45.65 Billion
Projected Market Size by 2033
6.20%
CAGR · 2026–2033
Download Free Sample View Report Summary
sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608
SHARE
BMIPUB00032581 56+ Countries Covered 10 Major Companies Profiled PEST & SWOT Analysis Competitive Heat Map
At a Glance

Report Coverage

56 +
Countries
56+ countries across North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa
12
Year Assessment
Comprehensive Market Analysis Covering 3 Years of Historical Data (2022–2024), Base Year (2025), and 8-Year Forecast (2026–2033)
10 +
Major Players
Major companies profiled including Bayer AG, Pfizer Inc., Janssen Global Services, LLC, Teva Pharmaceutical Industries Ltd., Merck Sharp & Dohme Corp.
400
Report Pages
Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets
What's Fueling Growth

Market Drivers

  • Rising demand for long-acting reversible options

  • Global surge in preventing various sexual illness

  • Growing preference for hormone-free birth control

Where Growth Opportunities Exist

Key Opportunities

  • Developing smart IUDs with digital health sensors

  • Expanding male barrier options for shared burden

  • Linking AI to predict individual fertility cycles

What Could Slow It Down

Market Restraints

  • Strict safety audits for implanted polymers

  • Complex regulatory hurdles for new medical device

  • High costs for next-gen long-term LARC insertion

Market Segmentation

Coverage by Segment

Product Type

Hormonal Contraceptives
Barrier Contraceptives

Type

Male Contraceptive Devices
Female Contraceptive Devices

Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Clinics
Geographic Breakdown

Regional Intelligence

NA North America
EU Europe
APAC Asia-Pacific
SCA South & Central America
MEA Middle East & Africa
Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

Bayer AG
Pfizer Inc.
Janssen Global Services, LLC
Teva Pharmaceutical Industries Ltd.
Merck Sharp & Dohme Corp.
Mylan N.V.
Reckitt Benckiser Group plc.
Veru Inc.
Medisafe Distribution Inc.
CooperSurgical, Inc.
What's Inside

Report Scope & Deliverables

Market Size 2025 US$ 28.22 Billion
Market Size 2033 US$ 45.65 Billion
CAGR 2026–2033 6.20%
Segments By Product Type (Hormonal Contraceptives, Barrier Contraceptives)  |  By Type (Male Contraceptive Devices, Female Contraceptive Devices)  |  By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics)
Geographies North America (US, Canada, Mexico)  ·  Europe (Belgium, Austria, Finland, Denmark, Greece, Poland, Romania, Russia, Ukraine, Czech Republic, Slovakia, Bulgaria, Italy, Luxembourg, Germany, Switzerland, France, Netherlands, Norway, Portugal, Spain, Sweden, United Kingdom)  ·  Asia-Pacific (Australia, China, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Bangladesh, New Zealand, Taiwan)  ·  South and Central America (Brazil, Argentina, Peru, Chile, Colombia)  ·  Middle East and Africa (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Turkiye, South Africa, Egypt, Algeria, Nigeria)
Deliverables Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code BMIPUB00032581
Lead Analyst Krishna Sunthwal — Analyst, Research · View Profile
With Full Report Access

Gain actionable insights with 400 pages of in-depth Contraceptive Devices Market, including historical trends, 8-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.

View Report Summary Download Free Sample